4D Molecular Therapeutics

4D Molecular Therapeutics

4D Molecular Therapeutics

4D Molecular Therapeutics’ mission is to design and develop transformative genetherapy products using our proprietary.
Founded
2013
Raised
$93M
Follow us
Alexa global traffic share
06 Sep 2018
$90,000,000
Venture capital (Series B)

4D Molecular Therapeutics Raises $90M in Series B Financing

FinSMEs
+1
19 Sep 2017
$3,000,000
Venture capital